Previous studies have shown that the loss of Mettl3 in hepatocytes promotes lipid accumulation in the liver and contributes to the progression of NAFLD [21, 23, 24]. This evidence concerns the gene METTL3 and metabolic dysfunction-associated steatotic liver disease.